Active surveillance: minimising treatment while maximising outcomes in testis cancer

por Conduit, Ciara, Tran, Ben
Publicado 2023

Precision oncology in urothelial cancer

por Liow, Elizabeth, Tran, Ben
Publicado 2020

Improving outcomes in germ cell cancers using miRNA

por Conduit, Ciara, Tran, Ben
Publicado 2021

Luminal-B breast cancer and novel therapeutic targets

por Tran, Ben, Bedard, Philippe L
Publicado 2011

The new era of prostate-specific membrane antigen-directed immunotherapies and beyond in advanced prostate cancer: a review

por Martin, Felicity C., Dorff, Tanya B., Tran, Ben
Publicado 2023

The impact of testicular cancer and its treatment on masculinity: A systematic review

por Dax, Victoria, Ftanou, Maria, Tran, Ben, Lewin, Jeremy, Wallace, Rebecca, Seidler, Zac, Wiley, Joshua F.
Publicado 2022

PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going?

por Giraudet, Anne-Laure, Kryza, David, Hofman, Michael, Moreau, Aurélie, Fizazi, Karim, Flechon, Aude, Hicks, Rodney J., Tran, Ben
Publicado 2021

A meta-analysis of clinicopathologic features that predict necrosis or fibrosis at post-chemotherapy retroperitoneal lymph node dissection in individuals receiving treatment for no...

por Conduit, Ciara, Hong, Wei, Martin, Felicity, Thomas, Benjamin, Lawrentschuk, Nathan, Goad, Jeremy, Grimison, Peter, Ahmadi, Nariman, Tran, Ben, Lewin, Jeremy
Publicado 2022

Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control Arm

por O’Haire, Sophie, Degeling, Koen, Franchini, Fanny, Tran, Ben, Luen, Stephen J, Gaff, Clara, Smith, Kortnye, Fox, Stephen, Desai, Jayesh, IJzerman, Maarten
Publicado 2022

Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up

por Conduit, Ciara, Koh, Thuan Tzen, Hofman, Michael S, Toner, Guy C, Goad, Jeremy, Lawrentschuk, Nathan, Tai, Keen-Hun, Lewin, Jeremy H, Tran, Ben
Publicado 2022

“Nothing to lose and the possibility of gaining”: a qualitative study on the feasibility and acceptability of registry-based randomised controlled trials among cancer patients and...

por Prang, Khic-Houy, Karanatsios, Bill, Zhang, Angela, Verbunt, Ebony, Wong, Hui-li, Wong, Vanessa, Gately, Lucy, Tran, Ben, Gibbs, Peter, Kelaher, Margaret
Publicado 2023

Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors

por Tran, Ben, Carvajal, Richard D., Marabelle, Aurelien, Patel, Sandip Pravin, LoRusso, Patricia M., Rasmussen, Erik, Juan, Gloria, Upreti, Vijay V., Beers, Courtney, Ngarmchamnanrith, Gataree, Schöffski, Patrick
Publicado 2018

A phase 1a/1b first-in-human study (COMPASSION-01) evaluating cadonilimab in patients with advanced solid tumors

por Frentzas, Sophia, Gan, Hui K., Cosman, Rasha, Coward, Jermaine, Tran, Ben, Millward, Michael, Zhou, Yiting, Wang, Wenjing, Xia, Dennis, Wang, Zhongmin Maxwell, Li, Baiyong, Xia, Michelle, Desai, Jayesh
Publicado 2023

Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer

por Millen, Rosemary, Malaterre, Jordane, Cross, Ryan S., Carpinteri, Sandra, Desai, Jayesh, Tran, Ben, Darcy, Phillip, Gibbs, Peter, Sieber, Oliver, Zeps, Nikolajs, Waring, Paul, Fox, Stephen, Pereira, Lloyd, Ramsay, Robert G.
Publicado 2016

Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG)

por Seidel, Christoph, Hentrich, Marcus, Zschäbitz, Stefanie, Paffenholz, Pia, Heidenreich, Axel, Nestler, Tim, Tran, Ben, Fischer, Stefanie, Daugaard, Gedske, Ochsenreither, Sebastian, Brito, Margarida, Zengerling, Friedemann, Schwab, Constantin, Bokemeyer, Carsten, Oing, Christoph
Publicado 2022

Leveraging Comprehensive Cancer Registry Data to Enable a Broad Range of Research, Audit and Patient Support Activities

por Lee, Belinda, Gately, Lucy, Lok, Sheau Wen, Tran, Ben, Lee, Margaret, Wong, Rachel, Markman, Ben, Dunn, Kate, Wong, Vanessa, Loft, Matthew, Jalili, Azim, Anton, Angelyn, To, Richard, Andrews, Miles, Gibbs, Peter
Publicado 2022

Futibatinib, an Irreversible FGFR1–4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF/FGFR Aberrations: A Phase I Dose-Expansion Study

por Meric-Bernstam, Funda, Bahleda, Rastislav, Hierro, Cinta, Sanson, Marc, Bridgewater, John, Arkenau, Hendrik-Tobias, Tran, Ben, Kelley, Robin Kate, Park, Joon Oh, Javle, Milind, He, Yaohua, Benhadji, Karim A., Goyal, Lipika
Publicado 2022

Molecular classification of hormone‐sensitive and castration‐resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specime...

por Yuen, Kobe C., Tran, Ben, Anton, Angelyn, Hamidi, Habib, Costello, Anthony J., Corcoran, Niall M., Lawrentschuk, Nathan, Rainey, Natalie, Semira, Marie C. G., Gibbs, Peter, Mariathasan, Sanjeev, Sandhu, Shahneen, Kadel, Edward E.
Publicado 2022

Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic Index

por Day, Daphne, Guo, Christina, Kanjanapan, Yada, Tran, Ben, Spreafico, Anna, Joshua, Anthony M, Wang, Lisa, Abdul Razak, Albiruni R, Leighl, Natasha B, Hansen, Aaron R, Butler, Marcus O, Siu, Lillian L, Desai, Jayesh, Bedard, Philippe L
Publicado 2019

CD8(+) tumor‐infiltrating lymphocytes within the primary tumor of patients with synchronous de novo metastatic colorectal carcinoma do not track with survival

por Millen, Rosemary, Hendry, Shona, Narasimhan, Vignesh, Abbott, Rebecca, Croxford, Matthew, Gibbs, Peter, Tie, Jeanne, Wong, Hui‐Li, Jones, Ian, Kosmider, Suzanne, Byrne, David, Zalcberg, John, Fox, Stephen, Desai, Jayesh, Visvanathan, Kumar, Ramsay, Robert G, Tran, Ben
Publicado 2020